Check out Medtech Insight's US FDA Warning Letter Data Tracker here.
This chart lists device-related warning letters released by the US Food and Drug Administration in September 2022. If an inspection...
Warning Letter Roundup & Recap – September 2022
Med Pen Concepts LLC was the only recipient of a device-related warning letter from the US Food and Drug Administration last month.
More from Regulation
• By
The US FDA needs to know who wants a seat at the MDUFA negotiations table before discussions can begin. The agency is asking stakeholders to let it know if they plan to participate in the periodic consultation meetings before July 28.
• By
Finland has initiated a project to improve the effectiveness of the monitoring of software intended for medical use and to ensure that software placed on its market meets the requirements set for it.
• By
To succeed in medtech, investors must focus on patient outcomes. Gilde Healthcare says involving patients boosts product effectiveness, access and market success — making it a smart strategy in today’s strained healthcare systems.
• By
MedTech Europe is ready to become involved and shape Europe’s Life Sciences Strategy and help drive regulatory simplification from the top to make the EU “the world’s most attractive place for life sciences by 2030.”